Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 21
Encontrada(s) 1 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

Phenomenological toy model for flash effect in proton therapy

  • García, G.
  • Llorena, D.
  • Illescas, Cristina
  • Viñals, S.
  • García, L.
  • Fernández de Barrena Machón, G.
  • Sánchez Parcerisa, Daniel
  • Ynsa, M. D.
We present a simple model based on general assumptions for the FLASH effect in radiotherapy, leading to a rate equation with only three free parameters. The model can predict the biological effect ratio between healthy and tumoral tissue for arbitrary input treatments, given as a dose rate versus time function. We analyze the behavior of the model and its sensitivity to its free parameters, and decide on suitable parameter values in accordance with available experimental data from the literature. Then we apply our model to study different sets of treatments, modeled as square pulse periodic functions with different pulse peak dose rate, pulse width and repetition period, in order to illustrate how it may be used to guide future experiment design. The model predicts that, for a given average dose rate above the FLASH threshold, a more prominent FLASH effect would be observed for continuous beams than for ultra-pulsated beams with an infinitely short irradiation time. This finding needs to be validated with suitable experiments.
Docta Complutense
Publication Artículo científico (JournalArticle)

Infrared molecular imaging of infarcted myocardium using rare earth nanoparticles and click chemistry

  • Didonè, Livia
  • Gutiérrez González, Paula
  • Qiu, Dongmei
  • Artiga, Álvaro
  • Ortgies, Dirk H.
  • Román Carmena, Marta
  • Amor, Sara
  • García-Villalón, Angel Luis
  • Granado, Miriam
  • Jaque García, Daniel
  • Villaverde Cantizano, Gonzalo
  • Rubio Retama, Benito Jorge
Fluorescence imaging using antibody-functionalized luminescent nanoparticles has shown promise for in vivo imaging of infarcted tissues; however, challenges such as suboptimal antibody orientation, increased hydrodynamic size, and reduced circulation times affect their targeting efficiency, hindering their clinical application. In this study, we propose to address these limitations by combining a pretargeting strategy with the overexpression of intercellular adhesion molecule 1 (ICAM-I) in infarcted myocardium, the sharp emission lines of infrared-emitting neodymium/ytterbium co-doped nanoparticles, and hyperspectral imaging technology. The feasibility of the method is demonstrated through ex vivo experiments and autofluorescence-free imaging of beating hearts, highlighting its potential as a high-contrast, non-invasive tool for myocardial infarction diagnosis.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Hydroxytyrosol Enhances Plasma Extracellular Vesicle Secretion, Modulates Their miRNAs Cargo, and Reduces LDL Oxidation in Humans: Postprandial and 1-Week Effects

  • Del Saz-Lara, Andrea
  • López de Las Hazas, María-Carmen
  • Tomé-Carneiro, Joao
  • Ávila-Gálvez, Maria-Ángeles
  • Crespo, María Carmen
  • Mazarío-Gárgoles, Carmen
  • Chapado, Luis A
  • Daimiel, Lidia
  • Visioli, Francesco
  • Martín-Santiago, Victoria
  • Espín de Gea, Juan Carlos
  • Dávalos, Alberto
Hydroxytyrosol (HT) consumption is associated with healthy outcomes. Specifically, its ability to modulate microRNA (miRNA) expression has been described. However, whether HT influences the secretion of extracellular vesicles (EVs) and their transported miRNAs remains unknown. Here, following HT administration, we explored the potential changes in EV secretion and in their miRNA cargo during postprandial state and after 1 week of daily intake. Twelve healthy participants received, first, a single 25 mg dose of HT (postprandial study) and then 25 mg HT daily, for one week (sustained study). Plasma and circulating plasma-isolated EVs were analyzed for HT and derived metabolites using UPLC-qTOF-MS and miRNAs by RNA-seq. HT induced the secretion of EVs 1-h post-ingestion and a 1-week daily administration of HT increased fasting EVs and reduced circulating oxidized LDL levels. RNA-seq analysis identified 55 modulated miRNAs (30 upregulated and 25 downregulated) related to response to oxygen level and gland development, following 1-week HT supplementation. This pilot study sheds light on the effects of HT consumption on EV secretion and modulation of exosomal miRNAs in humans, which has been scarcely studied to date. Further research is warranted to elucidate the molecular mechanisms underlying the observed effects., This research was funded by MCIN/ AEI /10.13039/501100011033 through the European and ERDF - “A way of making Europe” (PID2022-143100OB-I00 and PID2021-125899OB-I00), by the European Union NextGenerationEU/ PRTR (TED2021-130962B-C21 and TED2021-130962B-C22), by Comunidad de Madrid EXOHEP2-CM (S2022/BMD-7409), and by the AGROALNEXT program (MICIU, PRTR-C17.I1, Spain) with funding from the European Union NextGenerationEU (PRTR-C17.I1) and Fundación Séneca (Comunidad Autónoma Región de Murcia, Spain). M.C.L.H. is a recipient of a Ramon y Cajal Grant RYC2022-037626-I. C.M.-G. and L.B. are supported by a contract derived from Union NextGenerationEU/PRTR (TED2021-130962B-C21). A.S.-L. is supported by a predoctoral fellowship (N° 2021-01- PhD GRANT) from the International Olive Council. CIBEROBN (CB22/03/00068) is an initiative of the Instituto de Salud Carlos III, Spain. F.V. is partially funded by PRIN-2022 Prot. 2022NZNZH8., Peer reviewed
Docta Complutense
Publication Artículo científico (JournalArticle)

Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle

  • Cordani, Marco
  • Strippoli, Raffaele
  • Trionfetti, Flavia
  • Barzegar Behrooz, Amir
  • Rumio, Cristiano
  • Velasco, Guillermo
  • Ghavami, Saeid
  • Marcucci, Fabrizio
Inhibitory immune checkpoint (ICP) molecules are pivotal in inhibiting innate and acquired antitumor immune responses, a mechanism frequently exploited by cancer cells to evade host immunity. These evasion strategies contribute to the complexity of cancer progression and therapeutic resistance. For this reason, ICP molecules have become targets for antitumor drugs, particularly monoclonal antibodies, collectively referred to as immune checkpoint inhibitors (ICI), that counteract such cancer-associated immune suppression and restore antitumor immune responses. Over the last decade, however, it has become clear that tumor cell-associated ICPs can also induce tumor cell-intrinsic effects, in particular epithelial-mesenchymal transition (EMT) and macroautophagy (hereafter autophagy). Both of these processes have profound implications for cancer metastasis and drug responsiveness. This article reviews the positive or negative cross-talk that tumor cell-associated ICPs undergo with autophagy and EMT. We discuss that tumor cell-associated ICPs are upregulated in response to the same stimuli that induce EMT. Moreover, ICPs themselves, when overexpressed, become an EMT-inducing stimulus. As regards the cross-talk with autophagy, ICPs have been shown to either stimulate or inhibit autophagy, while autophagy itself can either up- or downregulate the expression of ICPs. This dynamic equilibrium also extends to the autophagy-apoptosis axis, further emphasizing the complexities of cellular responses. Eventually, we delve into the intricate balance between autophagy and apoptosis, elucidating its role in the broader interplay of cellular dynamics influenced by ICPs. In the final part of this article, we speculate about the driving forces underlying the contradictory outcomes of the reciprocal, inhibitory, or stimulatory effects between ICPs, EMT, and autophagy. A conclusive identification of these driving forces may allow to achieve improved antitumor effects when using combinations of ICIs and compounds acting on EMT and/or autophagy. Prospectively, this may translate into increased and/or broadened therapeutic efficacy compared to what is currently achieved with ICI-based clinical protocols.
Docta Complutense
Publication Artículo científico (JournalArticle)

Optimizing point source tracking in awake rat PET imaging: a comprehensive study of motion detection and best correction conditions

  • Arias Valcayo, Fernando
  • Galve Lahoz, Pablo
  • Udías Moinelo, José Manuel
  • Vaquero, Juan José
  • Desco, Manuel
  • Herraiz, Joaquín L.
  • López Herraiz, Joaquín
Preclinical PET animal studies require immobilization of the animal, typically accomplished through the administration of anesthesia, which may affect the radiotracer biodistribution. The use of (Formula presented.) F point sources attached to the rat head is one of the most promising methods for motion compensation in awake rat PET studies. However, the presence of radioactive markers may degrade image quality. In this study, we aimed to investigate the most favorable conditions for preclinical PET studies using awake rats with attached point sources. Firstly, we investigate the optimal activity conditions for the markers and rat-injected tracer using Monte Carlo simulations to determine the parameters of maximum detectability without compromising image quality. Additionally, we scrutinize the impact of delayed window correction for random events on marker detectability and overall image quality within these studies. Secondly, we present a method designed to mitigate the influence of rapid rat movements, which resulted in a medium loss of events of around 30%, primarily observed during the initial phase of the data acquisition. We validated our study with PET acquisitions from an awake rat within the acceptable conditions of activity and motion compensation parameters. This acquisition revealed an 8% reduction in resolution compared to a sedated animal, along with a 6% decrease in signal-to-noise ratio (SNR). These outcomes affirm the viability of our method for conducting awake preclinical brain studies.
Docta Complutense
Publication Artículo científico (JournalArticle)

Development and characterisation of a radiobiology proton beamline using radiochromic film dosimetry

  • Marques Coelho, Carina
  • de la Fuente Fernández, Pablo
  • Bononad, Paula
  • Viñals, Sílvia
  • Tavares de Sousa, Célia
  • Galaviz, Daniel
  • Herrera, Federico
  • del Monte-García, Inés
  • Sánchez Parcerisa, Daniel
  • Cortés-Llanos, Belén
Objective. To develop and optimise a dedicated low-energy proton beamline at the Centre for Micro-Analysis of Materials (CMAM, Madrid, Spain) for radiobiological applications. Approach. An automated irradiation system was implemented, integrating Gafchromic EBT3 radiochromic film dosimetry corrected for linear energy transfer dependent quenching and post-irradiation darkening. Dosimetric calibration was performed using multichannel analysis, and beam performance was systematically evaluated as a function of distance, raster scanning area, beam intensity and reproducibility. Main results. Optimal operating conditions were identified at moderate beam currents (⩽1nA) and scanning areas of 40 × 40 to 50 × 50mm2, yielding homogeneous dose distributions with reproducibility better than 8%. The dosimetric protocol demonstrated linearity across clinically relevant dose ranges and allowed a reliable correlation between irradiation parameters and absorbed dose. Proof-of-concept experiments on U-87 MG glioblastoma cells confirmed the system’s ability to deliver controlled and biologically effective proton exposures, as demonstrated by clonogenic survival assays. Significance. These results establish the CMAM implantation beamline as a robust and versatile platform for preclinical proton radiobiology, providing accurate dosimetric control and supporting investigations of relative biological efficacy. The system facilitates translational advances in proton radiobiology, bridging physical and biological studies in low-energy proton irradiation.
Archivo Digital UPM
Publication Artículo científico (JournalArticle)

Electromyography Gesture Model Classifier for Fault-Tolerant-Embedded Devices by Means of Partial Least Square Class Modelling Error Correcting Output Codes (PLS-ECOC)

  • Sarabia Ortiz, Pablo|||0000-0001-7391-8494
  • Araujo Pinto, Álvaro|||0000-0001-9269-5900
  • Sarabia Peinador, Luis Antonio|||0000-0002-5936-7929
  • Ortiz Fernández, María de la Cruz|||0000-0002-4751-8929
Archivo Digital UPM
Publication Artículo científico (JournalArticle)

Single-cell mechanical characterization in constriction-based cytometry

  • Abarca Ortega, Aldo Fabián|||0000-0002-1600-8555
  • González Bermúdez, Blanca|||0000-0002-1266-0917
  • Castro Dominguez, Cristina
  • Alvarez Lopez, Aroa|||0000-0003-3819-9644
  • Díaz Alcáraz, Cristina
  • Garvia Rodriguez, Maria
  • Guinea Tortuero, Gustavo Víctor|||0000-0002-4326-3746
  • Plaza Baonza, Gustavo Ramón|||0000-0002-5555-5498
Archivo Digital UPM
Publication Artículo científico (JournalArticle)

Enhancing Micropipette Aspiration with Artificial Intelligence Analysis

  • Abarca Ortega, Aldo Fabián|||0000-0002-1600-8555
  • González Bermúdez, Blanca|||0000-0002-1266-0917
  • Plaza Baonza, Gustavo Ramón|||0000-0002-5555-5498
Archivo Digital UPM
Publication Artículo científico (JournalArticle)

The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy

  • Rodríguez Ruiz, Emelina
  • Herrero Labrador, Raquel|||0000-0003-0169-5505
  • Fernández Fernández, Ana Patricia|||0000-0002-3843-4715
  • Serrano Masa, Julia|||0000-0002-0046-5495
  • Martínez Montero, José Antonio|||0000-0002-9748-021X
  • González Nieto, Daniel|||0000-0003-2972-729X
  • Hana Vaish, Mayuri|||0009-0003-8052-484X
  • Benchekroun, Mohamed|||0000-0002-0063-0139
  • Ismaili, Lhassane|||0000-0002-6013-3150
  • Marco Contelles, Jose|||0000-0003-0690-0328
  • Martínez Murillo, Ricardo|||0000-0003-3657-3890
Archivo Digital UPM
Publication Artículo científico (JournalArticle)

Preclinical examination of early-onset thalamic-cortical seizures after hemispheric stroke

  • García Peña, Pablo|||0000-0002-4928-0213
  • Ramos Gómez, Milagros|||0000-0001-5798-9508
  • López Navarro, Juan Manuel|||0000-0001-7847-8707
  • Martínez Murillo, Ricardo|||0000-0003-3657-3890
  • Arcas Castro, Guillermo de|||0000-0003-1699-7389
  • González Nieto, Daniel|||0000-0003-2972-729X
Archivo Digital UPM
Publication Artículo científico (JournalArticle)

A dataset with bilingual TV commands for silent speech interfaces using electroencephalographic signals

  • Lobo Alonso, Mario|||0009-0009-8567-8526
  • Martín Fernández, Iván|||0009-0004-2769-9752
  • Oropesa García, Ignacio|||0000-0003-4560-285X
  • Barra Chicote, Roberto|||0000-0003-0844-7037
  • Kontaxakis Antoniadis, Georgios|||0000-0001-6665-2501
  • San Segundo Hernández, Rubén|||0000-0001-9659-5464
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Integrin-Linked Kinase (ILK) promotes mitochondrial dysfunction by decreasing CPT1A expression in a folic acid-based model of kidney disease

  • Serna Soto, Mariano de la
  • Calleros Basilio, Laura|||0000-0001-7739-1319
  • Martos Elvira, María|||0009-0009-1071-4449
  • Moreno Piedra, Ariadna|||0009-0009-8919-3964
  • García Villoria, Sergio|||0009-0000-6085-5519
  • Griera Merino, Mercedes|||0000-0002-9887-6638
  • Alcalde Estévez, Elena|||0000-0002-2550-0293
  • Asenjo Bueno, Ana|||0000-0003-0561-8275
  • Rodríguez Puyol, Diego María|||0000-0002-9125-9311
  • Frutos García, Sergio de|||0000-0002-1225-5911
  • Ruiz Torres, María Piedad|||0000-0003-1640-7326
21 p., Integrin-linked kinase (ILK) is a key scaffolding protein between extracellular matrix protein and the cytoskeleton and has been implicated previously in the pathogenesis of renal damage. However, its involvement in renal mitochondrial dysfunction remains to be elucidated. We studied the role of ILK and its downstream regulations in renal damage and mitochondria function both in vivo and vitro, using a folic acid (FA)induced kidney disease model. Wild type (WT) and ILK conditional-knockdown (cKDILK) mice were injected with a single intraperitoneal dose of FA and studied after 15 days of chronic renal damage progression. Human Kidney tubular epithelial cells (HK2) were transfected with specific siRNAs targeting ILK, glycogen synthase kinase 3-? (GSK3?), or CCAAT/enhancer binding protein-? (C/EBP?). The expressions and activities of renal ILK, GSK3?, C/EBP?, mitochondrial oxidative phosphorylation enzymes, and mitochondrial membrane potential were assessed. Additionally, the expression of markers for fibrosis fibronectin (FN) and collagen 1 (COL1A1), for autophagy p62 and cytosolic light chain 3 (LC3B) isoforms II and I, and mitochondrial homeostasis marker carnitine palmitoyl-transferase 1A (CPT1A) were evaluated using immunoblotting, RT-qPCR, immunofluorescence, or colorimetric assays. FA upregulated ILK expression, leading to the decrease of GSK3? activity, increased tubular fibrosis, and produced mitochondrial dysfunction, both in vivo and vitro. These alterations were fully or partially reversed upon ILK depletion, mitigating FA-induced renal damage. The signaling axis composed by ILK, GSK3?, and C/EBP? regulated CPT1A transcription as the limiting factor in the FA-based impaired mitochondrial activity. We highlight ILK as a potential therapeutical target for preserving mitochondrial function in kidney injury., Instituto de Salud Carlos III, Comunidad de Madrid, Universidad de Alcalá, Fondo Europeo de Desarrollo Regional (FEDER)
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Potential anti-adhesion activity of novel carbosilane zwitterionic dendrimers against eukaryotic and prokaryotic pathogenic microorganisms

  • Gómez Casanova, Natalia|||0000-0002-6983-1895
  • Martín-Serrano Ortiz, Ángela|||0000-0002-2908-8910
  • Heredero Bermejo, Irene|||0000-0001-6984-1965
  • Sánchez-Nieves Fernández, Javier|||0000-0003-0410-2285
  • Copa Patiño, José Luis|||0000-0002-2162-3907
  • Mata de la Mata, Francisco Javier de la|||0000-0003-0418-3935
The development of biofilms on different surfaces continues to be a major public health problem. The antimicrobial resistance and the difficulty of finding drugs capable of combating these established biofilms generates the urgent need to find compounds that prevent cells from settling and establishing of these complex communities of microorganisms. Zwitterionic modification of nanomaterials allows the formation of a hydration layer, and this highly hydrophilic surface provides antifouling properties as well as a good biocompatibility by preventing non-specific interactions. Thus, they are appropriate candidates to prevent microbial adhesion to different surfaces and, in consequence, avoid biofilm formation. For this reason, we have incorporated zwitterionic moieties in multivalent systems, as are carbosilane dendrimers. Characterization of these systems was performed using nuclear magnetic resonance and mass spectrometry. It has been analysed if the new molecules have capacity to inhibit the biofilm formation in Candida albicans, Staphylococcus aureus and Pseudomonas aeruginosa. The results showed that they were more effective against S. aureus, observing a biofilm reduction of 81.5% treating with 32 mg/L of G2SiZWsf dendrimer and by 72.5% using 32 mg/L of the G3SiZWsf dendrimer. Finally, the absence of cytotoxicity was verified by haemolysis and cytotoxicity studies in human cells lines., Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain, Ministerio de Economía, Comercio y Empresa, Comunidad de Madrid
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Oxidative stress, lipid peroxidation and ferroptosis are major pathophysiological signatures in the placental tissue of women with late-onset preeclampsia

  • Ortega, Miguel A.
  • García Puente, Luis M.
  • Fraile Martínez, Óscar|||0000-0002-4494-6397
  • Pekarek, Tatiana
  • García Montero, Cielo|||0000-0001-6016-7855
  • Bujan, Julián
  • Pekarek, Leonel|||0000-0002-5966-9003
  • Barrena Blázquez, Silvestra|||0000-0003-2715-1979
  • Gragera Martínez, Raquel de los Reyes|||0000-0001-5694-8579
  • Rodríguez Rojo, Inmaculada C.
  • Rodríguez Benítez, Patrocinio
  • López González, Laura|||0009-0005-1023-7639
  • Díaz Pedrero, Raúl|||0000-0001-9318-4045
  • Álvarez de Mon Soto, Melchor|||0000-0003-1309-7510
  • García Honduvilla, Natalio Antonio|||0000-0003-0904-6198
  • León Luis, Juan A. de
  • Bravo Arribas, Coral
  • Saez, Miguel A.
Preeclampsia, a serious and potentially life-threatening medical complication occurring during pregnancy, is characterized by hypertension and often accompanied by proteinuria and multiorgan dysfunction. It is classified into two subtypes based on the timing of diagnosis: early-onset (EO-PE) and late-onset preeclampsia (LO-PE). Despite being less severe and exhibiting distinct pathophysiological characteristics, LO-PE is more prevalent than EO-PE, although both conditions have a significant impact on placental health. Previous research indicates that different pathophysiological events within the placenta may contribute to the development of preeclampsia across multiple pathways. In our experimental study, we investigated markers of oxidative stress, ferroptosis, and lipid peroxidation pathways in placental tissue samples obtained from women with LO-PE (n = 68) compared to healthy control pregnant women (HC, n = 43). Through a comprehensive analysis, we observed an upregulation of specific molecules associated with these pathways, including NADPH oxidase 1 (NOX-1), NADPH oxidase 2 (NOX-2), transferrin receptor protein 1 (TFRC), arachidonate 5-lipoxygenase (ALOX-5), acyl-CoA synthetase long-chain family member 4 (ACSL-4), glutathione peroxidase 4 (GPX4) and malondialdehyde (MDA) in women with LO-PE. Furthermore, increased ferric tissue deposition (Fe3+) was observed in placenta samples stained with Perls’ Prussian blue. The assessment involved gene and protein expression analyses conducted through RT-qPCR experiments and immunohistochemistry assays. Our findings underscore the heightened activation of inflammatory pathways in LO-PE compared to HC, highlighting the pathological mechanisms underlying this pregnancy disorder., Comunidad de Madrid, Instituto de Salud Carlos III
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

ILK deletion protects against chronic kidney disease-associated vascular damage

  • Campillo De Blas, Sofía
  • Gutiérrez Calabrés, Elena|||0000-0001-8144-6909
  • García Miranda, Susana
  • Griera Merino, Mercedes|||0000-0002-9887-6638
  • Frutos García, Sergio De|||0000-0002-1225-5911
  • Rodríguez Puyol, Diego María|||0000-0002-9125-9311
  • Calleros Basilio, Laura|||0000-0001-7739-1319
19 p., Cardiovascular diseases are a major cause of morbidity and mortality in chronic kidney disease (CKD) patients. Integrin-linked kinase (ILK) regulates integrin-extracellular matrix interactions and vascular integrity. This study investigated the role of ILK in CKD-associated vascular alterations. An adenine-supplemented diet induced a progressive CKD in wild-type (WT) and conditional ILK knock-down (cKD-ILK) mice. Aortic tissue was collected for histology and RT-qPCR analysis. Moreover, aortas were incubated ex vivo with the uremic toxins p-cresyl sulfate and indoxyl sulfate. In vitro, human aortic vascular smooth muscle cells were exposed to uremic toxins, and the effect of siRNA-mediated ILK silencing was tested. Aortas of adenine-fed WT mice showed a progressive increase in ILK expression, morphological alterations, and increased fibrosis, which was not observed in cKD-ILK aortas, compared to control mice. Statistically significant correlations between vascular content of ILK and fibrosis markers were observed. Ex vivo, uremic toxins increased ILK and fibrosis protein expression in WT aortas but not in cKD-ILK. In vitro, uremic toxins increased ILK activity and fibrosis markers, like collagen, while ILK-deleted cells prevented collagen increase. ILK depletion prevents CKD-associated vascular fibrosis, suggesting ILK as a potential therapeutic target to prevent arterial alterations in renal patients., Instituto de Salud Carlos III, Comunidad de Madrid, Universidad de Alcalá, Unión Europea, Fondo Europeo de Desarrollo Regional
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Assessing new collagen therapies for wound healing: a murine model approach

  • Benito Martínez, Selma|||0000-0002-3118-0564
  • Pérez Köhler, Bárbara|||0000-0002-5061-1526
  • Rodríguez Mancheño, Marta
  • Rivas Santos, Celia|||0009-0009-9215-3867
  • Izco, Jesús María
  • Recalde, José Ignacio
  • Pascual González, María Gemma|||0000-0002-1623-4384
Collagen proteins play important roles in wound healing and are of great interest in regenerative medicine. This study evaluated the efficacy of new collagen-based products and compared them to commercial products in a murine model of cutaneous healing. Circular excisional defects were generated on 72 Wistar rats. Six study groups were established according to the administered collagen treatment: Control (without treatment), SD-C (semidenatured), Catrix, Hy-C (hydrolyzed), N-C (native) and Helix3-CP. Seven and eighteen days post-surgery, animals were euthanized. Wound closure was macroscopically assessed by taking zenithal images of the defects. Morphological, histological and immunohistochemical studies were performed to evaluate the healing process. After 7 days, open areas and degree of epithelialization were similar among the groups. Significant differences were observed in contraction between control and the N-C and Helix3-CP groups. Untreated animals exhibited a more pronounced granulation tissue with a high number of inflammatory cells and a disorganised extracellular matrix with type III collagen deposition. After 18 days, animals treated with new collagen (Hy-C and N-C) exhibited accelerated wound closure, increased epithelialization and a more organised granulation tissue. Local administration of new collagen treatments promotes the progression of the reparative process and significantly accelerates wound closure compared with nontreated wounds., Comunidad de Madrid
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Do firms react to supply chain disruptions?

  • Lucio Fernández, Juan José De|||0000-0002-9335-6000
  • Díaz Mora, Carmen
  • Mínguez, Raúl
  • Minondo, Asier
  • Requena Silvente, Francisco
Since the outbreak of the Covid-19 pandemic, the disruption of supply chains has become a major concern for global firms. This article uses a representative sample of Spanish manufacturers that participate in global value chains to analyze whether firms are implementing strategies to respond to this concern. Using data for the period 2017?2022, we find that, on average, manufacturers have not increased the number of countries from which they source their input since the Covid-19 pandemic. Firms have not either shifted their imports to countries that are geographically and geopolitically close to Spain, and have not reshored imports. However, firms have significantly increased the stock of intermediates. Firms only diversify when they have one supplier, export to many destinations, and the imported input has a high risk of experiencing a supply chain disruption. Firms nearshore and friendshore when their main supplier is geographically distant., Ministerio de Ciencia e Innovación, Gobierno Vasco. Departamento de Educación, Comunidad de Madrid, Generalitat Valenciana
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Integrin-Linked Kinase (ILK) promotes mitochondrial dysfunction by decreasing CPT1A expression in a folic acid-based model of kidney disease

  • Serna Soto, Mariano de la
  • Calleros Basilio, Laura|||0000-0001-7739-1319
  • Martos Elvira, María|||0009-0009-1071-4449
  • Moreno Piedra, Ariadna|||0009-0009-8919-3964
  • García Villoria, Sergio|||0009-0000-6085-5519
  • Griera Merino, Mercedes|||0000-0002-9887-6638
  • Alcalde Estévez, Elena|||0000-0002-2550-0293
  • Asenjo Bueno, Ana|||0000-0003-0561-8275
  • Rodríguez Puyol, Diego María|||0000-0002-9125-9311
  • Frutos García, Sergio de|||0000-0002-1225-5911
  • Ruiz Torres, María Piedad|||0000-0003-1640-7326
Integrin-linked kinase (ILK) is a key scaffolding protein between extracellular matrix protein and the cytoskeleton and has been implicated previously in the pathogenesis of renal damage. However, its involvement in renal mitochondrial dysfunction remains to be elucidated. We studied the role of ILK and its downstream regulations in renal damage and mitochondria function both in vivo and vitro, using a folic acid (FA)-induced kidney disease model. Wild type (WT) and ILK conditional-knockdown (cKD-ILK) mice were injected with a single intraperitoneal dose of FA and studied after 15 days of chronic renal damage progression. Human Kidney tubular epithelial cells (HK2) were transfected with specific siRNAs targeting ILK, glycogen synthase kinase 3-β (GSK3β), or CCAAT/enhancer binding protein-β (C/EBPβ). The expressions and activities of renal ILK, GSK3β, C/EBPβ, mitochondrial oxidative phosphorylation enzymes, and mitochondrial membrane potential were assessed. Additionally, the expression of markers for fibrosis fibronectin (FN) and collagen 1 (COL1A1), for autophagy p62 and cytosolic light chain 3 (LC3B) isoforms II and I, and mitochondrial homeostasis marker carnitine palmitoyl-transferase 1A (CPT1A) were evaluated using immunoblotting, RT-qPCR, immunofluorescence, or colorimetric assays. FA upregulated ILK expression, leading to the decrease of GSK3β activity, increased tubular fibrosis, and produced mitochondrial dysfunction, both in vivo and vitro. These alterations were fully or partially reversed upon ILK depletion, mitigating FA-induced renal damage. The signaling axis composed by ILK, GSK3β, and C/EBPβ regulated CPT1A transcription as the limiting factor in the FA-based impaired mitochondrial activity. We highlight ILK as a potential therapeutical target for preserving mitochondrial function in kidney injury., Instituto de Salud Carlos III, Comunidad de Madrid, Universidad de Alcalá
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Role of calpains in uremia-related functional and structural muscle changes: protective effect of calpastatin overexpression

  • Gutiérrez Calabrés, Elena|||0000-0001-8144-6909
  • Campillo De Blas, Sofía
  • Alcalde Estévez, Elena|||0000-0002-2550-0293
  • Cuevas Delgado, Paula
  • Barbas Arribas, Coral
  • García Villoria, Sergio|||0009-0000-6085-5519
  • Silvestre Vargas, Alba
  • Griera Merino, Mercedes|||0000-0002-9887-6638
  • Frutos García, Sergio De|||0000-0002-1225-5911
  • Ruiz Torres, María Piedad|||0000-0003-1640-7326
  • Rodríguez Puyol, Diego María|||0000-0002-9125-9311
  • Calleros Basilio, Laura|||0000-0001-7739-1319
20 p., Sarcopenia, the progressive loss of muscle mass and strength, is a common complication in patients with chronic kidney disease (CKD). This condition arises from a combination of factors including reduced physical activity, insufficient protein intake, hyperphosphatemia, chronic inflammation, and uremia itself; however, the underlying molecular mechanisms remain poorly understood. Proteolysis in skeletal muscle is primarily controlled by the ubiquitin–proteasome system, autophagy–lysosome system, and calpains (CAPNs) cysteine proteases, which degrade structural proteins and mediate cell signaling. This study aims to investigate the role of CAPNs in CKD-associated muscle deterioration. CKD was induced in mice through an adenine-rich diet for 2, 4 and 6 weeks. The involvement of CAPNs in CKD-related sarcopenia was assessed using mice that overexpressed the CAPNs endogenous inhibitor, calpastatin (CAST). Gastrocnemius muscle strength, structural integrity, and function were evaluated. Mice with CKD showed elevated CAPNs, particularly CAPN2, expression and activity in the gastrocnemius, in parallel with significant muscle deterioration, including strength loss, structural damage, and impaired muscle performance. Overexpression of CAST prevented muscle strength loss, improved muscle function and structure without affecting renal function, and reversed fibrosis, inflammation and adipogenesis expression markers. Targeting CAPN2 could be a promising therapeutic strategy to mitigate muscle damage and improve physical performance in CKD patients., Ministerio de Economía y Competitividad, Instituto de Salud Carlos III, Unión Europea, Comunidad de Madrid, Universidad de Alcalá